刺激性肠综合征的新型CHRM3驱动的临床前模型
Junmin Yang1, Xueyang Li1,2, Chong Wang1
1Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
研究人员通过在肠道中表达人体受体, 开发了一种针对刺激性肠综合征 (IBS) 的新型小鼠模型. 这种模型准确地复制了IBS的症状和病理,
科学领域:
- 胃肠病学
- 动物模型
- 分子生物学
背景情况:
- 刺激性肠综合征 (IBS) 是一种常见的功能性胃肠疾病,影响生活质量.
- 现有的动物模型不充分反映IBS病理生理学.
- 需要更好的模型来研究IBS机制和治疗方法.
研究的目的:
- 开发和验证刺激性肠综合征 (IBS) 的新小鼠模型.
- 研究该模型对IBS病变和治疗策略的有用性.
主要方法:
- 在肠道上皮细胞中创建了具有人类肌酸乙胆受体3 (hCHRM3) 特定表达的小鼠模型.
- 使用克洛扎- N- 氧化物 (CNO) 激活hCHRM3,诱发IBS类症状.
- 分析了生理,病理,分子 (RNA测序) 和微生物组的变化.
主要成果:
- 模型小鼠表现出关键的IBS症状 (腹,疼痛,过敏) 和病理变化 (,炎症,屏障破坏).
- RNA测序发现了显著的基因表达差异,特别是在免疫和炎症途径上.
- 观察到短链脂肪酸和肠道微生物组成的变化.
结论:
- 这种表达hCHM3的小鼠模型有效地模仿了人类的IBS症状和病理.
- 该模型是促进IBS研究和开发新疗法的宝贵工具.
更多相关视频
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
09:44Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
相关概念视频
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
